Patents by Inventor Md Harunur RASHID

Md Harunur RASHID has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PORCINE G-CSF VARIANTS AND THEIR USES
    Publication number: 20230340051
    Abstract: The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed.
    Type: Application
    Filed: January 30, 2023
    Publication date: October 26, 2023
    Inventors: Peter Connor CANNING, Nickolas KNUDSEN, Md Harunur RASHID
  • INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF
    Publication number: 20230226152
    Abstract: The present invention provides compositions and methods comprising interleukin-2 (TL-2) polypeptide conjugates. Also described are IL-2 conjugates for the treatment of diseases or conditions including cancer.
    Type: Application
    Filed: September 7, 2022
    Publication date: July 20, 2023
    Inventors: Sigeng CHEN, Yingchun LU, Md Harunur RASHID, Nickolas KNUDSEN, Feng TIAN
  • Porcine G-CSF variants and their uses
    Patent number: 11578111
    Abstract: The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: February 14, 2023
    Assignees: Elanco US Inc., Ambrx, Inc.
    Inventors: Peter Connor Canning, Nickolas Knudsen, Md Harunur Rashid
  • INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES
    Publication number: 20220056093
    Abstract: The present invention provides methods for targeting interleukin-2 receptor-expressing cells, and, in particular, inhibiting the growth of such cells by using an interleukin-2 (IL-2) variant conjugated to a biologically active molecule that will affect cells expressing the interleukin-2 receptor.
    Type: Application
    Filed: September 11, 2019
    Publication date: February 24, 2022
    Applicant: Ambrx, Inc.
    Inventors: Sigeng CHEN, Yingchun Lu, MD Harunur Rashid, Nickolas Knudsen, Feng Tian
  • INTERLEUKIN-10 POLYPEPTIDE CONJUGATES, DIMERS THEREOF, AND THEIR USES
    Publication number: 20220009986
    Abstract: The present invention provides methods for targeting interleukin-10 receptor-expressing cells, and, in particular, inhibiting the growth of such cells by using an interleukin-10 (IL-10) variant conjugated to a biologically active molecule that will affect cells expressing the interleukin-10 receptor.
    Type: Application
    Filed: October 19, 2019
    Publication date: January 13, 2022
    Applicant: Ambrx, Inc.
    Inventors: Mingchao Kang, Yingchun Lu, Nickolas Knudsen, MD Harunur Rashid, Feng Tian
  • Anti-CD3 Antibody Folate Bioconjugates and Their Uses
    Publication number: 20210317213
    Abstract: Described herein are novel anti-CD3 Folate antibodies and uses thereof in the treatment of diseases or conditions that would benefit from such.
    Type: Application
    Filed: August 28, 2019
    Publication date: October 14, 2021
    Applicant: Ambrx, Inc.
    Inventors: Md Harunur Rashid, Ying Sun, Feng Tian, Sung Ju Moon
  • A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION
    Publication number: 20210108213
    Abstract: Disclosed herein are methods, compositions and components for optimizing or increasing expression of a protein, polypeptide or fragment therefrom.
    Type: Application
    Filed: May 1, 2019
    Publication date: April 15, 2021
    Applicant: Ambrx, Inc.
    Inventors: MD Harunur RASHID, Mark SHIMAZU, Feng Tian
  • PORCINE G-CSF VARIANTS AND THEIR USES
    Publication number: 20210054039
    Abstract: The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed.
    Type: Application
    Filed: October 10, 2018
    Publication date: February 25, 2021
    Applicants: Elanco US Inc., Ambrx, Inc.
    Inventors: Peter Connor CANNING, Nickolas KNUDSEN, Md Harunur RASHID